DYNC1H1
Overview[edit | edit source]
DYNC1H1 is a gene that encodes the cytoplasmic dynein 1 heavy chain 1 protein, which is a crucial component of the dynein motor complex. This complex is responsible for retrograde intracellular transport along microtubules, playing a vital role in various cellular processes, including mitosis, organelle transport, and cell signaling.
Structure[edit | edit source]
The DYNC1H1 gene is located on chromosome 14 in humans and spans approximately 1.5 million base pairs. The protein product of DYNC1H1 is a large polypeptide with a molecular weight of approximately 532 kDa. It contains several functional domains, including the motor domain responsible for ATP hydrolysis and microtubule binding, and the tail domain, which interacts with cargo and other dynein subunits.
Function[edit | edit source]
DYNC1H1 is a key component of the cytoplasmic dynein complex, which is involved in the transport of various cellular cargos, such as organelles, protein complexes, and mRNA, towards the minus end of microtubules. This retrograde transport is essential for maintaining cellular organization and function. Dynein also plays a critical role in mitosis, where it helps in the positioning of the mitotic spindle and the segregation of chromosomes.
Clinical Significance[edit | edit source]
Mutations in the DYNC1H1 gene have been associated with several neurological disorders, including Charcot-Marie-Tooth disease, spinal muscular atrophy, and intellectual disability. These mutations can lead to defects in neuronal transport, resulting in neurodegeneration and other clinical manifestations.
Research and Developments[edit | edit source]
Recent studies have focused on understanding the precise mechanisms by which DYNC1H1 mutations lead to disease, as well as exploring potential therapeutic strategies to correct or compensate for these defects. Advances in CRISPR-Cas9 technology and other gene-editing tools hold promise for developing targeted treatments for conditions associated with DYNC1H1 mutations.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD